Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Expanded capital investment centered on AI-related demand, higher volumes of semiconductor materials, strong sales of various products, and the impact of volume, price-volume balance and foreign exchange rates. In the food business, higher raw material and packaging material prices, increased manufacturing costs and lower volumes were factors behind the decline in profit.
No applicable items
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥223,151 million (YoY +14.0%) |
| Operating profit | ¥27,678 million (YoY +40.0%) |
| Ordinary income | ¥28,497 million (YoY +42.5%) |
| Profit attributable to owners of the parent | ¥19,010 million (YoY +53.1%) |
| Net income per share | ¥195.66 |
| Equity ratio | End of the current fiscal period 57.4% / End of previous period 56.0% |
| Total assets | ¥578,865 million |
| Net assets | ¥391,810 million |
| Cash flows from operating activities | ¥38,424 million |
| Cash flows from investing activities | ¥-15,654 million |
| Cash flows from financing activities | ¥-19,331 million |
| Cash and cash equivalents at end of period | ¥91,596 million |
| Full-year earnings forecast | Net Sales ¥468,000 million (YoY +12.3%) / Operating profit ¥53,000 million (YoY +27.4%) / Ordinary income ¥53,000 million (YoY +23.9%) / Net income ¥33,500 million (YoY +20.2%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥468,000 million / Operating profit Not disclosed → ¥53,000 million / Ordinary income Not disclosed → ¥53,000 million / Net income Not disclosed → ¥33,500 million |
| Annual Dividend Forecast | ¥112 → ¥140（+25.0%） |
| Segment revenue | Chemicals Business ¥126,033 million (YoY +20.2%), Food Business ¥43,313 million (YoY +6.5%), Life Sciences Business ¥50,070 million (YoY +5.0%) |
| Segment profit | Chemicals Business ¥20,373 million (YoY +56.2%), Food Business ¥1,329 million (YoY -35.7%), Life Sciences Business ¥5,489 million (YoY +32.0%) |
| Depreciation and amortization | ¥9,929 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥108 million, Gain on sale of investment securities ¥235 million / Extraordinary loss Loss on disposal of fixed assets ¥427 million, Loss on sale of non-current assets ¥64 million |
| Disclosure regarding the going concern assumption | No applicable items |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 98,944,242 shares |
| Treasury Shares at Period-End | 1,896,772 treasury shares |
| Factors Behind Changes in Business Performance | Expanded capital investment centered on AI-related demand, higher volumes of semiconductor materials, strong sales of various products, and the impact of volume, price-volume balance and foreign exchange rates. In the food business, higher raw material and packaging material prices, increased manufacturing costs and lower volumes were factors behind the decline in profit. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The chemicals and life sciences businesses reported higher sales and operating profit, driven by expanded sales of semiconductor materials against a backdrop of AI-related demand, higher volumes across various products, improvements in prices and volumes, and the impact of foreign exchange rates. The food business, however, reported lower operating profit due to higher raw material and packaging material prices, increased manufacturing costs, and lower volumes of products such as shortening for confectionery applications.